TFM
KYMR icon

TFC Financial Management’s Kymera Therapeutics KYMR Stock Holding History

TFC Financial Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115 Hold
1
– – ﹤0.01% 904
2026
Q1 		$84 Buy
+1
New +$79 ﹤0.01% 894

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

TFC Financial Management's KYMR Position: Q2 2026 in Review

TFC Financial Management held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 1 share worth $115. The position accounts for ﹤0.01% of the portfolio, ranked #904.

TFC Financial Management first reported a position in KYMR in Q1 2026 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • TFC Financial Management held 1 share of Kymera Therapeutics worth $115 as of Q2 2026.
  • TFC Financial Management left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #904 holding.
  • TFC Financial Management first reported a position in Kymera Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.